altimmune glp 1 ADA 2024: Altimmune's GLP-1 drug shows weight loss potential #glp1 #glucagon #mash #masld #obesity
Description
GLP-1 receptor agonists, including semaglutide and tirzepatide, have revolutionized the approach to weight loss
In the last 20 years, the emergence of pharmacological treatments for obesity based on gastrointestinal hormones has transformed the ...
Future clinical trials should aim to distinguish the direct analgesic effects of GLP-1RAs from their metabolic benefits and explore their broader applications in pain conditions
Today, drugs like Ozempic (semaglutide), Wegovy, and Mounjaro (tirzepatide) are being prescribed and demanded for obesity
GLP-1 and similar hormone-activating medications can significantly reduce appetite, support weight loss and control blood sugar
